Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity.
Iron binding in the sera of 35 patients with beta thalassaemia major and intermedia was studied. In patients receiving regular blood transfusions since infancy transferrin was completely saturated and about 2.7--7.1 mumol/l of the serum iron could be removed by dialysis or ultrafiltration in the presence of a chelating agent or by filtration on DEAE-Sephadex-catecholdisulphonic acid columns. In contrast, less than 1.0 mumol/l of transferrin bound iron was removed when subjected to the same procedures. The non-specific iron of thalassaemic sera could no longer be demonstrated after incubation with normal serum. These findings indicate that non-specific iron is a chelatable with normal serum. These findings indicate that non-specific iron is a chelatable compound which is readily available for transferrin binding. In view of the known toxicity of unbound iron, its identification in thalassaemic sera might be of relevance to the pathogenesis of tissue damage and the protective effect of iron chelating therapy in this disease.
D000293:Adolescent; D000328:Adult; D001803:Blood Transfusion; D002648:Child; D002852:Chromatography, Ion Exchange; D004591:Electrophoresis, Polyacrylamide Gel; D005293:Ferritins / Q000097:blood; D006801:Humans; D007501:Iron / Q000097:blood*; D004369:Pentetic Acid / Q000494:pharmacology; D013789:Thalassemia / Q000097:blood*; D014168:Transferrin / Q000378:metabolism; D014462:Ultrafiltration
D014168:Transferrin; D004369:Pentetic Acid; D005293:Ferritins; D007501:Iron